Ameriprise
DRNA

Ameriprise’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Ameriprise’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,063
Closed -$564K – 4008
2021
Q1 		$564K Sell
22,063
-29,929
-58% -$764K ﹤0.01% 3353
2020
Q4 		$1.15M Sell
51,992
-26,186
-33% -$577K ﹤0.01% 3028
2020
Q3 		$1.41M Sell
78,178
-100
-0.1% -$2.07K ﹤0.01% 2831
2020
Q2 		$1.99M Buy
78,278
+1,648
+2% +$35.5K ﹤0.01% 2610
2020
Q1 		$1.41M Buy
+76,630
New +$1.49M ﹤0.01% 2661
2014
Q2 		– Sell
-86,678
Closed -$2.45M – 5686
2014
Q1 		$2.45M Buy
+86,678
New +$3.22M ﹤0.01% 2401

Other funds holding DRNA

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise's DRNA Position: Q2 2021 in Review

Ameriprise sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q2 2021, closing a stake of 22,063 shares — an estimated $564K sold.

Ameriprise first reported a position in DRNA in Q1 2014 and held it in 6 quarters. The position peaked at $2.45M in Q1 2014. 203 funds tracked by Wall St. Rank hold DRNA as of Q2 2021.

  • Ameriprise reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Ameriprise sold 22,063 Dicerna Pharmaceuticals, Inc. shares in Q2 2021, an estimated $564K.
  • Ameriprise first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 6 quarters.
  • Ameriprise's Dicerna Pharmaceuticals, Inc. position peaked at $2.45M in Q1 2014.
  • 203 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2021.

Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.